Latest Tetralogy of Fallot Stories
ATLANTA, Jan. 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has promoted David C. Gale, Ph.D., to the position of Vice President, Research and Development; and David P. Lang to the newly created position of Vice President, Market Development Surgical Adhesives and Starch Medical Relations. Dr. Gale will report to Steven G. Anderson, President and...
ATLANTA, Nov. 21, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at The New York Palace Hotel in New York City. Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present at 4:00 p.m. Eastern Time. CryoLife's live...
ATLANTA, Nov. 3, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets Eighth Annual Healthcare Conference on Tuesday, November 15, 2011 at 3:00 pm ET in New York City. CryoLife is also scheduled to present at the Stephens, Inc Fall...
ATLANTA, Oct. 17, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 third quarter financial results will be released on Thursday, October 27, 2011. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief...
ATLANTA, Oct. 13, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that ValveXchange, Inc., a company in which CryoLife owns a minority interest, has completed the first three human implants with its novel Vitality(TM) two-part heart valve system. The surgeries were performed in Asuncion, Paraguay and took place on Sept. 26 and 27, 2011. Three men aged 49, 62 and 72 received the...
ATLANTA, July 20, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 second quarter financial results will be released on Thursday, July 28, 2011. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive...
"Darth Vader" Among Kids Speaking Out for Children's Access to Services ALEXANDRIA, Va., June 22, 2011 /PRNewswire-USNewswire/ -- Although they are the youngest patients in the health care system, they know firsthand how open heart surgery, organ transplants or physical therapy can transform a life. More than 25 children and their families will travel from around the nation to share their stories with Capitol Hill lawmakers during the National Association of Children's Hospitals (N.A.C.H.)...
St. Joseph's Children's Hospital is among a small number of facilities in the country to offer the less-invasive procedure for valve replacement. TAMPA, Fla., June 9, 2011 /PRNewswire-USNewswire/ -- When cardiologists at St. Joseph's Children's Hospital told 21-year-old Adam Romano that he needed to have his pulmonary valve replaced, the diagnosis was not a surprise. Born with the congenital heart defect Tetralogy of Fallot, Adam underwent open-heart surgery when he was 2 years old and his...
ATLANTA, April 25, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011. BioGlue received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for use in the repair of aortic dissections in September 2010. Prior to distribution, MHLW completed a...
ATLANTA, April 18, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2011 first quarter financial results will be released on Thursday, April 28, 2011. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive officer...
